Related Experiment Video
Updated: Dec 12, 2025

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Persistent Hyperinsulinemic Hypoglycemia with Pancreatic Teratoma in Infancy: A Case Report
Ayse Pinar Cemeroglu1, Faik Sarialioglu2, Fatma Burcu Belen-Apak2
1Deparment of Pediatric Endocrinology, Faculty of Medicine, Baskent University, Ankara, Turkey.
Insights
A rare pancreatic teratoma caused severe hypoglycemia in an infant. Surgical removal cured the condition, highlighting a unique link between teratomas and hyperinsulinemic hypoglycemia in pediatrics.
Area of Science:
- Pediatric Surgery
- Endocrinology
- Developmental Biology
Background:
- Intraabdominal pancreatic teratomas are exceptionally rare in children.
- Severe hyperinsulinemic hypoglycemia is a critical condition in infants.
Observation:
- A 6-month-old infant presented with lethargy and abnormal eye movements, diagnosed with hyperinsulinemic hypoglycemia.
- Abdominal imaging revealed a large intraabdominal mass, initially suspected to be fetus in fetu, but histopathology confirmed a mature teratoma with immature pancreatic tissue.
- The mass was surgically excised, and the infant's hypoglycemia resolved post-operatively.
Findings:
- This is the first reported case of severe hyperinsulinemic hypoglycemia in an infant caused by an intraabdominal teratoma.
- Genetic analysis revealed heterozygous variations in HNF1ß and IRS1 genes, suggesting a role in the teratoma's embryogenesis and associated hypoglycemia.
- No mutations in the ABCC8 gene were found, ruling out common causes of congenital hyperinsulinism.
Implications:
- This case expands the differential diagnosis for infantile hyperinsulinemic hypoglycemia.
- It underscores the importance of thorough investigation for ectopic teratomas in unexplained hypoglycemia cases.
- The findings suggest a potential genetic predisposition involving HNF1ß and IRS1 in the development of pancreatic teratomas and hypoglycemia.
Abstract:
BACKGROUND Pediatric intraabdominal pancreatic teratomas have been rarely reported. This is the first case of severe hyperinsulinemic hypoglycemia in a 6-month-old infant secondary to an intraabdominal teratoma. The hypoglycemia resolved after surgical removal. CASE REPORT A 6-month-old infant was seen in a pediatric emergency department with complaints of lethargy and abnormal eye movements. She was diagnosed with hyperinsulinemic hypoglycemia and started on diazoxide. A CT and MRI of the abdomen revealed a 165×77×72 mm cyst with a 51×45×30 mm solid structure connecting to the wall of the cyst by a stalk, raising suspicion of a fetus in fetu. The mass had no connection to her pancreas. Following total excision of the intraabdominal mass, her hypoglycemia resolved. Histopathological examination showed immature fetal pancreatic tissue consistent with a mature teratoma. Whole exon sequencing of the infant's peripheral blood showed a negative mutation of ABCC8 and presence of heterozygous variations of HNF1ß and IRS1 genes. CONCLUSIONS This is the first case report of an infant with severe hyperinsulinemic hypoglycemia secondary to a pancreatic teratoma. The heterozygous variations of HNF1ß and IRS1 genes likely played a role in the embryogenesis, causing a pancreatic teratoma and hyperinsulinemic hypoglycemia.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

